Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2

Status

Completed 4Withdrawn 2Terminated 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1

Conditions

Head and Neck Neoplasms 2Depression 2Stomatitis 1Pancreatic Neoplasms 1Pain, Intractable 1Laparoscopic Colorectal Resection Due to Cancer 1Anxiety Disorders 1Agnosia 1

Interventions

Therapeutics 2Psychiatric Rehabilitation 2Ketamine 2Venlafaxine Hydrochloride 1Psilocybin 1Holistic Health 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Depression × Ketamine × Clear all
NCT05344625 2024-01-24

KAPTIVATED

Northwell Health

Phase EARLY_PHASE1 Withdrawn

Anxiety Disorders, Depression

NCT02442739 2018-11-06

Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers

Cedars-Sinai Medical Center

Phase EARLY_PHASE1 Withdrawn
GastrointestinalHead & Neck

Depression, Head and Neck Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡